Burma Spore Syringe

The Burma strain stands out in a field where most cubensis genetics have anonymous origins. This variety was reportedly collected in Myanmar (Burma) by John W. Allen, a published American ethnomycologist who spent decades documenting psychoactive fungi across Southeast Asia. That documented provenance makes Burma one of the few cubensis strains with a traceable collector and geographic record — a detail that matters when studying genetics and regional variation.

Microscopy Characteristics

Burma spores are ellipsoid, dark purplish-brown, measuring approximately 8.5–10 x 5.5–7 micrometres. Spore deposits are consistently dense — Burma is a strong spore producer, placing it in the top tier for syringe yield alongside B+ and Amazonian. Compared to other Southeast Asian strains, Burma spores are slightly more uniform in size distribution within a single deposit, making slide preparation more consistent.

Strain Background

John W. Allen is an ethnomycologist who has published extensively on psychoactive fungi in Southeast Asia. The Burma strain reportedly entered circulation through his collecting work in Myanmar during the 1990s. The strain is sometimes listed as Burmese by other vendors — both names refer to the same genetics.

Storage & Handling

Store at 2–8°C (35–46°F) in a dark location. Do not freeze. Viable for 6–12 months when properly refrigerated. Shake gently before use to redistribute settled spore material.

Frequently Asked Questions

Who collected the Burma cubensis strain?
The Burma strain is attributed to John W. Allen, an American ethnomycologist who spent decades documenting psychoactive fungi across Southeast Asia. He collected specimens in Myanmar during the 1990s and is a published researcher with numerous papers on psychoactive mushroom species in the region.

Every syringe is prepared in our Canadian cleanroom under 99.99% HEPA-filtered laminar flow hoods and visually inspected under magnification before shipping.